Literature DB >> 11535797

The VanY(D) DD-carboxypeptidase of Enterococcus faecium BM4339 is a penicillin-binding protein.

Peter E Reynolds1, O Herman Ambur1, Barbara Casadewall2, Patrice Courvalin2.   

Abstract

VanD-type Enterococcus faecium BM4339 is constitutively resistant to vancomycin and to low levels of teicoplanin. This strain produces peptidoglycan precursors terminating in D-lactate but, unlike VanA- and VanB-type strains, E. faecium BM4339 has a mutated ddl ligase gene and cannot synthesize D-Ala-D-Ala. Consequently, although it possesses vanX(D) and vanY(D) genes, it should not require an active VanX-type DD-dipeptidase or a VanY-type DD-carboxypeptidase for resistance. The vanY(D) gene contains the signatures of a penicillin-binding protein (PBP) and is believed to encode a penicillin-sensitive DD-carboxypeptidase. The enzyme activity was found to be membrane-bound and inhibited by low concentrations of benzylpenicillin in membrane preparations and in intact bacteria, indicating that the active site was present on the outside surface of the membrane. The 38 kDa protein was revealed as a PBP present in more copies per cell than conventional PBPs and all the protein was accessible to benzylpenicillin added externally, confirming the localization of the active site. A glycopeptide-susceptible strain of E. faecium lacked this PBP, and the membrane-bound DD-carboxypeptidase activity was less than 5% of that of E. faecium BM4339. Although the active site of VanY(D) was external to the membrane, UDP-MurNAc-tetrapeptide was produced internally, probably from UDP-MurNAc-pentadepsipeptide. The presence of benzylpenicillin at low concentrations in the growth medium substantially reduced the amount of tetrapeptide produced, indicating that inhibition of VanY(D) by benzylpenicillin influenced production of peptidoglycan precursors internally. A model to explain these contrasting observations is proposed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535797     DOI: 10.1099/00221287-147-9-2571

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  11 in total

1.  VanE-type vancomycin-resistant Enterococcus faecalis clinical isolates from Australia.

Authors:  Lorena Abadía-Patiño; Keryn Christiansen; Jan Bell; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil.

Authors:  Luca Guardabassi; Bruno Perichon; Jean van Heijenoort; Didier Blanot; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium.

Authors:  François Lebreton; Florence Depardieu; Nancy Bourdon; Marguerite Fines-Guyon; Pierre Berger; Sabine Camiade; Roland Leclercq; Patrice Courvalin; Vincent Cattoir
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

4.  Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus.

Authors:  Bruno Périchon; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-Resistant Stenotrophomonas maltophilia in a Mouse Model.

Authors:  Pengjun Han; Wenjing Zhang; Mingfang Pu; Yahao Li; Lihua Song; Xiaoping An; Mengzhe Li; Fei Li; Shuyan Zhang; Huahao Fan; Yigang Tong
Journal:  Front Microbiol       Date:  2022-07-05       Impact factor: 6.064

Review 6.  VanD-type vancomycin-resistant Enterococcus faecium 10/96A.

Authors:  Florence Depardieu; Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 7.  Lipid intermediates in the biosynthesis of bacterial peptidoglycan.

Authors:  Jean van Heijenoort
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

8.  Characterization of new L,D-endopeptidase gene product CwlK (previous YcdD) that hydrolyzes peptidoglycan in Bacillus subtilis.

Authors:  Tatsuya Fukushima; Yang Yao; Toshihiko Kitajima; Hiroki Yamamoto; Junichi Sekiguchi
Journal:  Mol Genet Genomics       Date:  2007-06-23       Impact factor: 3.291

9.  Characterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4.

Authors:  Bokyung Son; Jiae Yun; Jeong-A Lim; Hakdong Shin; Sunggi Heu; Sangryeol Ryu
Journal:  BMC Microbiol       Date:  2012-03-15       Impact factor: 3.605

10.  AmiA is a penicillin target enzyme with dual activity in the intracellular pathogen Chlamydia pneumoniae.

Authors:  Anna Klöckner; Christian Otten; Adeline Derouaux; Waldemar Vollmer; Henrike Bühl; Stefania De Benedetti; Daniela Münch; Michaele Josten; Katja Mölleken; Hans-Georg Sahl; Beate Henrichfreise
Journal:  Nat Commun       Date:  2014-06-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.